Bulk active chemical post approval changes
Answers
Answered by
0
Answer:
Answer:
The US Food and Drug Administration has issued a Guidance for Industry entitled BACPAC I: Intermediates in Drug Substance Synthesis but has yet to issue a companion document that would cover postapproval changes from the final intermediate to the active pharmaceutical ingredient (API).
Similar questions